Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

about

Prospective observational study in two Dutch hospitals to assess the performance of inflammatory plasma markers to determine disease severity of viral respiratory tract infections in children.

P2860

Q40138935-A8DD768D-0B38-45DE-AE5A-216AD4486302

P2860

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

Item

http://www.wikidata.org/entity/Q40162622

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

@en

type

Item

label

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

@en

prefLabel

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

@en

P1476

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection

@en

P2093

Eu Kyoung Lee

http://www.w3.org/2001/XMLSchema#string

Hwan Soo Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Hee Kim

http://www.w3.org/2001/XMLSchema#string

Jin Tack Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Seo Yoon

http://www.w3.org/2001/XMLSchema#string

Sulmui Won

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of nasopharyngeal flocked swabs and nasopharyngeal wash collection methods for respiratory virus detection in hospitalized children using real-time polymerase chain reaction.

Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study.

Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

Pattern recognition by pentraxins

The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity.

Management of severe community-acquired pneumonia of children in developing and developed countries.

Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines.

Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.

Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.

P304

42-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PPUL.23199

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoon Hong Chun

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25832310

http://www.w3.org/2001/XMLSchema#string

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

about

P2860

P2860

Pentraxin 3 as a clinical marker in children with lower respiratory tract infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698